期刊文献+

miRNA-21 regulates proatherosclerotic gene expression in macrophages

miRNA-21 regulates proatherosclerotic gene expression in macrophages
原文传递
导出
摘要 Background MicroRNAs (miRNANAs) are endogenous, small non-coding RNAs that negatively regulate gene expression in diverse cardiovascular diseases. However, the roles of miRNANAs in atherosclerogenesis needs to be elucidated. In the present study, the effect of miRNA-21 on pro-atherosclerotic genes expression was examined. Methods The pro-atherosclerotic genes including COX2, VCAM1, ICAM1, MCP1 and miRNA-21 were detected in ox-LDL-treated mouse macrophage RAW264.7 cells. ApoE knock-out (ApoE- KO) mice were fed with high-fat diet for 16 weeks, and the abdominal aorta were fixed and used for miRNA- 21 hybridization. Lentivirus-based vectors for enforced expression of miRNA-21 and antisense miRNA-21were prepared. The expression of proatherosclerotic genes was determined in the RAW264.7 cells with lentivirus- mediated up-regulation of miRNA-21. Results COX2, VCAM1, ICAM1 and MCP1 could be up-regulated by ox-LDL treatment, and 50 Ixg/mL ox-LDL could significantly increase the expression of above four genes in ox-LDL EAW264.7 cells, miRNA-21 could also be markedly up-regulated in ox-LDL-induced RAW264.7 cells. The result of miRNANA hybridization showed that miRNA-21 was strongly expressed in atherosclerotic plaques but not in normal aorta. Lentivirus-mediated over-expression of miRNA-21 could significantly enhance expressions of COX2, VCAM1, ICAM1 and MCP1 in RAW264.7 cells, which could be reversed by antisense miRNA-21 mediated by lentivirus vector. Conclusions miRNA-21 could be modulated by ox-LDL in macrophage RAW264.7 cells, and miRNA-21 could enhance COX2, VCAM1, ICAM1 and MCP1 expressions in macrophages. Background MicroRNAs (miRNANAs) are endogenous, small non-coding RNAs that negatively regulate gene expression in diverse cardiovascular diseases. However, the roles of miRNANAs in atherosclerogenesis needs to be elucidated. In the present study, the effect of miRNA-21 on pro-atherosclerotic genes expression was examined. Methods The pro-atherosclerotic genes including COX2, VCAM1, ICAM1, MCP1 and miRNA-21 were detected in ox-LDL-treated mouse macrophage RAW264.7 cells. ApoE knock-out (ApoE- KO) mice were fed with high-fat diet for 16 weeks, and the abdominal aorta were fixed and used for miRNA- 21 hybridization. Lentivirus-based vectors for enforced expression of miRNA-21 and antisense miRNA-21were prepared. The expression of proatherosclerotic genes was determined in the RAW264.7 cells with lentivirus- mediated up-regulation of miRNA-21. Results COX2, VCAM1, ICAM1 and MCP1 could be up-regulated by ox-LDL treatment, and 50 Ixg/mL ox-LDL could significantly increase the expression of above four genes in ox-LDL EAW264.7 cells, miRNA-21 could also be markedly up-regulated in ox-LDL-induced RAW264.7 cells. The result of miRNANA hybridization showed that miRNA-21 was strongly expressed in atherosclerotic plaques but not in normal aorta. Lentivirus-mediated over-expression of miRNA-21 could significantly enhance expressions of COX2, VCAM1, ICAM1 and MCP1 in RAW264.7 cells, which could be reversed by antisense miRNA-21 mediated by lentivirus vector. Conclusions miRNA-21 could be modulated by ox-LDL in macrophage RAW264.7 cells, and miRNA-21 could enhance COX2, VCAM1, ICAM1 and MCP1 expressions in macrophages.
出处 《South China Journal of Cardiology》 CAS 2014年第1期55-63,83,共10页 岭南心血管病杂志(英文版)
基金 supported by Grants from the National Natural Science Foundation of China(No.81070102,81270222,81273516,81302779) the Natural Science Foundation of the Guangdong Province(No.S2011020005911,S2012010009453)
关键词 ATHEROSCLEROSIS MICRORNAS pro-atherosclerotic genes MACROPHAGES atherosclerosis microRNAs pro-atherosclerotic genes macrophages
  • 相关文献

参考文献27

  • 1Jialal I, Devaraj S. The role of oxidized low density lipoprotein in atherogenesis. J Nutr 1996, 126: 1053- 1057.
  • 2Lusis AJ. Atherosclerosis. Nature 2000, 407: 233-241.
  • 3Condorelli G, Latronico MV, Dora GW Ⅱ. MicroRNAs in heart disease: putative novel therapeutic targets Eur Heart J 2010, 31: 649-658.
  • 4Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010, 121: 1022-1032.
  • 5van Rooij E, Olson EN. Searching for miR-acles in cardiac fibrosis. Circ Res 2009, 104:138-140.
  • 6Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107: 677-684.
  • 7Wu W, Xiao H, Laguna-Femandez A, et al. Flow- dependent regulation of Kruppel-like factor 2 is mediated by microRNA-92a. Circulation 2011, 124: 633-641.
  • 8Ni CW, Qiu H, Jo H: MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol 2011, 300:1762-1769.
  • 9Qin x, Wang x, Wang Y, et al. MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc Natl Acad Sci USA 2010, 107: 3240-3244.
  • 10Wang KC, Garmire LX, Young A, et al. Role of microRNA-23b in flow-regulation of Rb phosphorylafion and endothelial cell growth. Proc Natl Acad Sci USA 2010, 107:3234-3239.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部